Fonte: European Journal of Immunology. Unidade: FMRP
Assuntos: MACRÓFAGOS, DOENÇAS AUTOIMUNES (EXPERIMENTAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JIANG, Hui-Rong et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages. European Journal of Immunology, v. 42, n. 7, p. 1804-1814, 2012Tradução . . Disponível em: https://doi.org/10.1002/eji.201141947. Acesso em: 01 out. 2024.APA
Jiang, H. -R., Milovanovic, M., Allan, D., Niedbala, W., Besnard, A. -G., Fukada, S. Y., et al. (2012). IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages. European Journal of Immunology, 42( 7), 1804-1814. doi:10.1002/eji.201141947NLM
Jiang H-R, Milovanovic M, Allan D, Niedbala W, Besnard A-G, Fukada SY, Alves Filho JCF, Togbe D, Goodyear CS, Linington C, Xu D, Lukic ML, Liew FY. IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages [Internet]. European Journal of Immunology. 2012 ; 42( 7): 1804-1814.[citado 2024 out. 01 ] Available from: https://doi.org/10.1002/eji.201141947Vancouver
Jiang H-R, Milovanovic M, Allan D, Niedbala W, Besnard A-G, Fukada SY, Alves Filho JCF, Togbe D, Goodyear CS, Linington C, Xu D, Lukic ML, Liew FY. IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages [Internet]. European Journal of Immunology. 2012 ; 42( 7): 1804-1814.[citado 2024 out. 01 ] Available from: https://doi.org/10.1002/eji.201141947
